Literature DB >> 29314218

Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease-A pilot randomised controlled trial.

John V Hindle1, Tamlyn J Watermeyer2, Julie Roberts3, Andrew Brand4, Zoe Hoare4, Anthony Martyr5, Linda Clare5.   

Abstract

OBJECTIVE: To examine the appropriateness and feasibility of cognitive rehabilitation for people with dementias associated with Parkinson's in a pilot randomised controlled study.
METHODS: This was a single-blind pilot randomised controlled trial of goal-oriented cognitive rehabilitation for dementias associated with Parkinson's. After goal setting, participants were randomised to cognitive rehabilitation (n = 10), relaxation therapy (n = 10), or treatment-as-usual (n = 9). Primary outcomes were ratings of goal attainment and satisfaction with goal attainment. Secondary outcomes included quality of life, mood, cognition, health status, everyday functioning, and carers' ratings of goal attainment and their own quality of life and stress levels. Assessments were at 2 and 6 months following randomisation.
RESULTS: At 2 months, cognitive rehabilitation was superior to treatment-as-usual and relaxation therapy for the primary outcomes of self-rated goal attainment (d = 1.63 and d = 1.82, respectively) and self-rated satisfaction with goal attainment (d = 2.04 and d = 1.84). At 6 months, cognitive rehabilitation remained superior to treatment-as-usual (d = 1.36) and relaxation therapy (d = 1.77) for self-rated goal attainment. Cognitive rehabilitation was superior to treatment as usual and/or relaxation therapy in a number of secondary outcomes at 2 months (mood, self-efficacy, social domain of quality of life, carers' ratings of participants' goal attainment) and at 6 months (delayed recall, health status, quality of life, carer ratings of participants' goal attainment). Carers receiving cognitive rehabilitation reported better quality of life, health status, and lower stress than those allocated to treatment-as-usual.
CONCLUSIONS: Cognitive rehabilitation is feasible and potentially effective for dementias associated with Parkinson's disease.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Parkinson's disease; cognitive rehabilitation; dementia; dementia with Lewy bodies; quality of life

Mesh:

Year:  2018        PMID: 29314218     DOI: 10.1002/gps.4845

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  11 in total

Review 1.  Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review.

Authors:  Bhavana Patel; David J Irwin; Daniel Kaufer; Bradley F Boeve; Angela Taylor; Melissa J Armstrong
Journal:  Alzheimer Dis Assoc Disord       Date:  2022 Jan-Mar 01       Impact factor: 2.357

Review 2.  Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease.

Authors:  Max J Hulshoff; Elaine Book; Nabila Dahodwala; Caroline M Tanner; Christina Robertson; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

Review 3.  The design, evaluation, and reporting on non-pharmacological, cognition-oriented treatments for older adults: Results of a survey of experts.

Authors:  Sharon Sanz Simon; Mary Castellani; Sylvie Belleville; Tzvi Dwolatzky; Benjamin M Hampstead; Alex Bahar-Fuchs
Journal:  Alzheimers Dement (N Y)       Date:  2020-06-07

Review 4.  Cognitive Interventions in Parkinson's Disease: Where We Want to Go within 20 Years.

Authors:  Elke Kalbe; Dag Aarsland; Ann-Kristin Folkerts
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

5.  Cognitive Stimulation for Individuals with Parkinson's Disease Dementia Living in Long-Term Care: Preliminary Data from a Randomized Crossover Pilot Study.

Authors:  Ann-Kristin Folkerts; Miriam E Dorn; Mandy Roheger; Marco Maassen; Janneke Koerts; Oliver Tucha; Mareike Altgassen; Alexander T Sack; Diede Smit; Lena Haarmann; Elke Kalbe
Journal:  Parkinsons Dis       Date:  2018-12-02

6.  Proactive and Integrated Management and Empowerment in Parkinson's Disease: Designing a New Model of Care.

Authors:  Emma Tenison; Agnes Smink; Sabi Redwood; Sirwan Darweesh; Hazel Cottle; Angelika van Halteren; Pieter van den Haak; Ruth Hamlin; Jan Ypinga; Bastiaan R Bloem; Yoav Ben-Shlomo; Marten Munneke; Emily Henderson
Journal:  Parkinsons Dis       Date:  2020-03-30

7.  One-Year Change in Locus of Control among People with Dementia.

Authors:  Ingeborg Halse; Guro Hanevold Bjørkløf; Knut Engedal; Geir Selbæk; Maria Lage Barca
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-12-07

8.  Dementia subtype and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study.

Authors:  Yu-Tzu Wu; Linda Clare; John V Hindle; Sharon M Nelis; Anthony Martyr; Fiona E Matthews
Journal:  BMC Med       Date:  2018-09-11       Impact factor: 8.775

9.  Living with dementia with Lewy bodies: an interpretative phenomenological analysis.

Authors:  Victoria Larsson; Axel Holmbom-Larsen; Gustav Torisson; Eva Lena Strandberg; Elisabet Londos
Journal:  BMJ Open       Date:  2019-01-29       Impact factor: 2.692

10.  Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations.

Authors:  Sietske A M Sikkes; Yi Tang; Roos J Jutten; Linda M P Wesselman; Lyn S Turkstra; Henry Brodaty; Linda Clare; Erin Cassidy-Eagle; Kay L Cox; Gaël Chételat; Sophie Dautricourt; Klodian Dhana; Hiroko Dodge; Rose-Marie Dröes; Benjamin M Hampstead; Thomas Holland; Amit Lampit; Kate Laver; Antoine Lutz; Nicola T Lautenschlager; Susan M McCurry; Franka J M Meiland; Martha Clare Morris; Kimberly D Mueller; Ruth Peters; Gemma Ridel; Aimee Spector; Jenny T van der Steen; Jeanette Tamplin; Zara Thompson; Alex Bahar-Fuchs
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.